Filter by:

Trends in dedicated care for females with bleeding disorders within U.S. hemophilia treatment centers

Wheeler AP, Lim MY, Huguelet PS, Jaffray J, Staber JM, Funkhouser K, Carpenter SL, and Weyand AC

Hemostatic considerations for gender affirming care

Garland, K, Mullins, E, Bercovitz, RS, Rodriguez, V, Connors, J, and Sokkary, N

Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial

Ragni MV, Rothenberger SD, Feldman R, Nance D, Leavitt AD, Malec L, Kulkarni R, Sidonio R Jr, Kraut E, Lasky J, Pruthi R, Angelini D, Philipp C, Hwang N, Wheeler AP, Seaman C, Machin N, Xavier F, Meyer M, Bellissimo D, Humphreys G, Smith KJ, Merricks EP, Nichols TC, Ivanco D, Vehec D, Koerbel G, Althouse AD.

Menstrual Technology Innovations and the Implications for Heavy Menstrual Bleeding

Liberty, A., Samuelson Bannow, B., Matteson, K., Edelman, A., & Colwill, A.